Opportunistic infections by Brucella anthropi and Brucella intermedia: a case series of rare non-brucellosis diseases in Saudi Arabia
Abstract
BACKGROUND: Recently reclassified under the Brucella genus, Ochrobactrum species are rare opportunistic pathogens in immunocompromised hosts, causing non-brucellosis diseases. They exhibit multi-drug resistance (including AmpC) and often require combination therapy. This is the first study from Saudi Arabia to review infections by Brucella anthropi and Brucella intermedia, focusing on clinical significance, resistance, and outcomes. METHOD: A retrospective review was conducted on infections caused by B. anthropi and B. intermedia between January 2016 to December 2024. Data on patient demographics, infection type and location, microbial identification, and resistance patterns were collected. Treatment and therapy duration were reviewed, along with outcome assessment. Analysis of the rate of recovery and in-hospital mortality was performed. RESULTS: Over 8 years, a total of 18 unique cases were identified, after excluding 2 of which were deemed contaminated, totaling 16 cases included, 14 adult and 2 pediatric patients were identified as true infections. Presentations varied between septic shock, respiratory distress, and/or altered mental status. Diagnoses included catheter-related bloodstream infections (n = 9), intra-abdominal infection with or without bacteremia (n = 4), and VAP in the neonate (n = 2), catheter-associated urinary tract infection (CAUTI) (n = 1). B. anthropi was found in eleven (11/16) cases, and B. intermedia in four cases, in addition to one that was not…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 9 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.